Investors Information
EDAP TMS Investors Information
EDAP TMS (NASDAQ: EDAP) is the global leader in therapeutic ultrasound. EDAP TMS develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. EDAP TMS has an active operating worldwide network of corporate offices, subsidiaries, and distribution partners. By investing in Research & Development, EDAP TMS is committed to partnering with world-class research laboratories and internationally renowned medical institutions. Over the course of the last 40 years, EDAP TMS has developed a robust patent portfolio based on its innovative technologies.
EDAP TMS (NASDAQ: EDAP) is the global leader in therapeutic ultrasound. EDAP TMS develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. EDAP TMS has an active operating worldwide network of corporate offices, subsidiaries, and distribution partners. By investing in Research & Development, EDAP TMS is committed to partnering with world-class research laboratories and internationally renowned medical institutions. Over the course of the last 40 years, EDAP TMS has developed a robust patent portfolio based on its innovative technologies.
Join USC’s leading urologic team for a live procedure and discussion on the use of focal therapy with robotic HIFU as a tool in the comprehensive management of prostate cancer. Presented by Amir H. Lebastchi, MD, Assistant Professor of Clinical Urology, Keck Medicine of USC: https://youtu.be/ZrGRqd4zXPc
To view a replay of our Urology Expert Panel and live Focal One Demonstration held in New York on September 29, 2022, please use the following link: https://lifesci.rampard.com/WebcastingAppv5/Events/eventsDispatcher.jsp?Y2lk=MjAxNg
Please visit our EDAP TMS SA website or the links below for more information on EDAP technologies and to review investor information.
News & Events | Financial Information | Corporate Governance